Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a Locations section listing state sites (Arizona, California, Colorado, Massachusetts, New Jersey, Pennsylvania, Washington) and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the previous revision tag (v3.3.2).
    Difference
    0.8%
    Check dated 2025-12-23T20:37:49.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision entries were updated to v3.3.2 and v3.2.0 was removed, reflecting internal version control rather than substantive changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:24:03.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    - Removed the government funding status notice banner from the page; core study content, eligibility criteria, and results information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:22.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Minor UI/formatting adjustments were made to the Study Details page without altering core study information such as eligibility criteria, primary outcomes, or enrollment status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:04:46.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and version bump from v3.1.0 to v3.2.0, with links to official status pages.
    Difference
    2%
    Check dated 2025-10-06T05:24:59.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:02:38.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.